Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of outer membrane protein in preparation of malignant tumor immunotherapy drugs

A technology for immunotherapy drugs and outer membrane proteins, applied in the field of medicine, can solve problems such as undisclosed effects, and achieve the effect of inhibiting tumor growth and reducing tumor load

Active Publication Date: 2019-12-13
君维安(武汉)生命科技有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The patent application number CN008050937 discloses the use of enterobacterial OmpA protein combined with antigen for generating anti-viral, anti-Jiazoan, or anti-tumor cytotoxic response, which corresponds Klebsiella pneumoniae membrane protein to tumor Antigens are combined to prepare combined drugs to treat tumors. The patent application number 2010105017674 discloses the application of SJ16 protein in the preparation of immunosuppressive drugs. It uses SJ16 protein to prepare immunosuppressive drugs. Through the immune tolerance mechanism and induction, it can be used to a large extent. To avoid toxic and side effects, although it can inhibit the transformation and proliferation of tumor cells, it does not reveal the impact on the microenvironmental effect T lymphocytes in tumor cell immunotherapy, which has great shortcomings in the microenvironment regulation of tumor immunotherapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of outer membrane protein in preparation of malignant tumor immunotherapy drugs
  • Application of outer membrane protein in preparation of malignant tumor immunotherapy drugs
  • Application of outer membrane protein in preparation of malignant tumor immunotherapy drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: Materials and methods

[0044] 1. Outer membrane protein expression

[0045] 1. Use Escherichia coli engineering bacteria BL21 strain for heterologous expression, high-efficiency expression of genes cloned in expression vectors (such as pET series) containing phage T7 promoter, the plasmid PET 28a-Amuc used in this experiment, the map is as attached figure 1 , the Amuc protein gene is introduced into PET 28a through genetic engineering, and the plasmid PET28a-Amuc containing the Amuc protein gene is constructed. The method of constructing the plasmid is a conventional genetic engineering technique, which will not be repeated here. Cultivate overnight on LB+KanR resistant plate, select monoclonal antibody, transfer to 100ml LB+KanR resistant liquid medium, overnight, transfer to 200ml LB+KanR resistant liquid medium according to the ratio of 1:100, 37 Cultivate at ℃ for 2-3 hours, so that OD=0.6, 8000r / min, centrifuge for 5min, discard the supernatant, and st...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Mwaaaaaaaaaa
Login to View More

Abstract

The invention discloses an application of an outer membrane protein in preparation of malignant tumor immunotherapy drugs. The outer membrane protein is an outer membrane protein of akkermansia, can reduce tumor load, inhibit tumor growth and activate T cell related anti-tumor immune response, and can be applied to preparation of various malignant tumor immunotherapy drugs.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of an outer membrane protein in the preparation of immunotherapeutic drugs for malignant tumors. Background technique [0002] Immunotherapy has become an emerging tumor therapy after surgery, radiotherapy, and chemotherapy, gradually showing its irreplaceable advantages. Tumor occurrence is usually accompanied by the exhaustion of the body's immune system. The purpose of immunotherapy is to reduce the exhaustion level of the body, reshape the immune system, and help the body eliminate tumor cells. The inflammatory microenvironment formed by inflammatory cells and mediators (cytokines, chemokines, etc.) is an important component of the tumor microenvironment. It is closely related to the immune surveillance and immune escape of tumors, and participates in the occurrence, development, invasion and metastasis of tumors. and other processes. A variety of inflamm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/16A61P35/00
CPCA61K38/164A61P35/00
Inventor 刘智杨祥良石林林
Owner 君维安(武汉)生命科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com